MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Validation of Direct/Indirect targets with intra-operative clinical assessment in the Indian population & comparison with image guided and MER based targeting for Subthalamic Nucleus(STN) based Deep Brain Stimulation(DBS) in Parkinson’s disease(PD)

    A. Uppar, D. Srinivas, R. Yadav, P. Pal, V. Holla (BANGALORE, India)

    Objective: This study attempts to validate the relationship between Direct-D, indirect-ID coordinates for STN in Indian subjects.  Also, this study tries to compare the D,…
  • 2022 International Congress

    Cross-cultural validation of the Cebuano version of a screening questionnaire for Parkinson’s Disease

    D. Dakay, F. Tangcalagan, E. Villanueva Iii, J. Abejero, G. Saranza (Mandaue City, Philippines)

    Objective: To determine the validity of the Cebuano version of a PD screening questionnaire Background: In the Philippines, actual prevalence of Parkinson’s Disease (PD) is…
  • 2022 International Congress

    COMBINED CSF α-SYN RT-QuIC, CSF NFL AND MIDBRAIN-PONS PLANIMETRY IN DEGENERATIVE PARKINSONISMS: FROM BEDSIDE TO BENCH, AND BACK AGAIN

    C. Painous, M. Soto, M. Pulido-Salgado, M. Fernández, A. Camara, V. Sánchez, N. Bargallo, N. Caballol, C. Pont-Sunyer, M. Buongiorno, N. Martin, M. Basora, M. Tio, D. Giraldo, A. Pérez-Soriano, I. Zaro, E. Muñoz, MJ. Marti, F. Valldeoriola, Y. Compta (Barcelona, Catalonia)

    Objective: (1) to assess the combined diagnostic ability of CSF NFL, CSF RT-QuIC α-SYN and midbrain/pons MRI measures in degenerative parkinsonisms; (2) to interpret results…
  • 2022 International Congress

    Parkinson’s Progression Marker Initiative (PPMI) Online identifies people with features of prodromal Parkinson’s Disease through online questionnaires

    E. Brown, L. Chahine, D. Alonso, C. Coffey, R. Dobkin, T. Foroud, M. Korell, A. Lorenzo, C. Marras, W. Poewe, T. Sherer, A. Siderowf, T. Simuni, E. Tolosa, J. Valverde Twiggs, D. Weintraub, S. Chowdhury, K. Marek, C. Tanner (San Francisco, USA)

    Objective: To implement staged screening to identify people with features of prodromal Parkinson’s disease (PD). Background: The subtle motor and non-motor symptoms that occur prior…
  • 2022 International Congress

    Altered visual network dynamics associated with freezing of gait in Parkinson’s disease

    D. Su, L. Ji, Y. Cui, J. Zhou, T. Wu, J. Stoessl, Y. Liu, T. Feng (Beijing, China)

    Objective: We aimed to characterize the dynamic functional connectivity (DFC) in people with FOG based on high temporal-resolution functional MRI (fMRI). Background: Freezing of gait…
  • 2022 International Congress

    Motor Fluctuations development is associated with non-motor symptoms burden progression in Parkinson´s disease patients. A 2-year follow-up study.

    D. Santos, T. de Deus, C. Cores, M. Feal Painceiras, E. Suárez Castro, C. Martínez, S. Jesús, M. Aguilar, P. Pastor, L. Planellas, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, V. Gómez Mayordomo, V. Nogueira, V. Puente, J. Dotor, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo, J. Martínez Castrillo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Blázquez, M. Seijo, J. Ruíz Martínez, C. Valero, M. Kurtis, O. de Fábregues, J. González, R. Alonso Redondo, C. Ordás, L. López Díaz, D. Mcafee, P. Martínez Martín, P. Mir, C. Coppadis (A Coruña, Spain)

    Objective: The aim of the present study was to analyze the progression of non-motor symptoms (NMS) burden in Parkinson´s disease (PD) patients regarding the development…
  • 2022 International Congress

    Determination of metabotropic glutamate receptor 2/3 distribution with [3H]-LY-341,495 in Parkinson’s disease patients with visual hallucinations

    D. Bedard, E. Kim, I. Frouni, P. Huot (Montreal, Canada)

    Objective: To determine the distribution and levels of metabotropic glutamate 2/3 (mGlu2/3) receptors in brain tissue from patients with Parkinson’s disease (PD) with visual hallucinations (VHs).…
  • 2022 International Congress

    Socio-economic factors influencing Parkinson’s disease self-management

    L. Ambrosio, C. Rodríguez-Blazquez, M. Rodriguez Violante, T. Arakaki, N. Garretto, M. Serrano-Dueñas, I. Ibañez (Southampton, United Kingdom)

    Objective: To identify the socioeconomical factors associated with self-management Parkinson’s disease (PD). Background: Understanding and evaluating how PD patients manage their disease is paramount to…
  • 2022 International Congress

    CAREGIVERS BURDEN IN CARING FOR PERSONS WITH PARKINSON’S DISEASE: A SURVEY FROM A TEACHING HOSPITAL IN GHANA

    M. Agoriwo, D. Markwei, E. Womorde (Ho, Ghana)

    Objective: To determine the burden of caregivers in caring for persons with Parkinson’s disease (PD) and establish the relationship between the burden of care and…
  • 2022 International Congress

    Longitudinal study of Parkinson’s disease-related pattern with resting state functional MRI

    A. Vo, N. Nguyen, D. Eidelberg (Manhasset, USA)

    Objective: To validate the previously characterized resting-state fMRI (rs-fMRI) Parkinson’s disease (PD)-related pattern, termed fPDRP, in a large multi-site PD imaging database, and to assess…
  • « Previous Page
  • 1
  • …
  • 201
  • 202
  • 203
  • 204
  • 205
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley